NCT00000625已完成2 期
A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
National Institute of Allergy and Infectious Diseases (NIAID)103 个研究点 分布在 1 个国家目标入组 2,100 人开始时间: 2001年8月31日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 2,100
- 试验地点
- 103
研究概览
简要总结
To determine the efficacy and safety of zidovudine ( AZT ) versus didanosine ( ddI ), AZT plus ddI, and AZT plus zalcitabine ( ddC ) in preventing disease progression in HIV-infected patients with CD4 counts of 200-500 cells/mm3.
详细描述
Patients are randomized to receive AZT alone, AZT and ddI, AZT and ddC, or ddI alone for at least 2 years. Patients who develop AIDS or whose CD4 count falls to 50 percent or less of baseline are crossed over to another treatment arm.
PER AMENDMENT 4/5/95: Study treatment will be available until 10/31/95 at the latest for patients still taking study medications on 4/30/95, so that follow-up trials may be completed and approved.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (103)
Loading locations...
相似试验
已完成
2 期
A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)HIV InfectionsNCT00000781National Institute of Allergy and Infectious Diseases (NIAID)1,292
已完成
3 期
A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected ChildrenHIV InfectionsNCT00000637National Institute of Allergy and Infectious Diseases (NIAID)819
已完成
2 期
A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine TreatmentHIV InfectionsNCT00000671National Institute of Allergy and Infectious Diseases (NIAID)750
已完成
2 期
The Effectiveness of Two Anti-HIV Treatments in HIV-Infected PatientsHIV InfectionsNCT00001057National Institute of Allergy and Infectious Diseases (NIAID)105
已完成
2 期
A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 InfectionHIV InfectionsNCT00000823National Institute of Allergy and Infectious Diseases (NIAID)85